417TiPA phase 1 study of oral LOXO 292 in adult patients with advanced solid tumors, including RET-fusion non-small cell lung cancer, medullary thyroid cancer and other tumors with increased RET activity
Drilon, A.E., Bauer, T.M., Subbiah, V., Cabanillas, M., Lahkani, N., Wirth, L., Oxnard, G., Smith, S., Eary, T., Cruickshank, S., Nguyen, M., Rothenberg, S.Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx367.050
Date:
September, 2017
File:
PDF, 53 KB
english, 2017